(R)-2-((3,5-dimethyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole

ID: ALA4458111

Chembl Id: CHEMBL4458111

PubChem CID: 92975736

Max Phase: Preclinical

Molecular Formula: C17H16F3N3O2S

Molecular Weight: 383.39

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cnc(C[S@@+]([O-])c2nc3ccccc3[nH]2)c(C)c1OCC(F)(F)F

Standard InChI:  InChI=1S/C17H16F3N3O2S/c1-10-7-21-14(11(2)15(10)25-9-17(18,19)20)8-26(24)16-22-12-5-3-4-6-13(12)23-16/h3-7H,8-9H2,1-2H3,(H,22,23)/t26-/m1/s1

Standard InChI Key:  FPVRBOKLMQOBQO-AREMUKBSSA-N

Associated Targets(Human)

SARM1 Tchem NAD(+) hydrolase SARM1 (87 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 383.39Molecular Weight (Monoisotopic): 383.0915AlogP: 3.82#Rotatable Bonds: 5
Polar Surface Area: 73.86Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.35CX Basic pKa: 4.67CX LogP: 3.55CX LogD: 3.54
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.68Np Likeness Score: -1.08

References

1.  (2018)  INHIBITORS OF SARM1 NADase ACTIVITY AND USES THEREOF, 

Source